Skip to main content
OpenTrials
Completed

NCT Number: NCT03211611

Management of Women With BRCA1/2 Mutation

The aim of this study is to determine general practitionners' role in management of women with BRCA1/2 mutation.

This study will be conduct between April 2017 and December 2017 at Montpellier University Hospital on women followed-up in the department of genetics and their general practitionners (GP). Patients and their GP will be called by the investigators and questionnaire will be given to them. Questionnaire includes questions for patients and their GP. The primary endpoint was to determine the rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation. Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions. Secondary endpoint was to determine women' opinion on their GP : whether or not well managed for their BRCA 1 / 2 mutation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

BRCA1 Mutation BRCA2 Mutation Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

About this study

PURPOSE: The aim of this study is to determine general practitionners' role in management of women with BRCA1/2 mutation.

METHODS:

This study will be conduct between April 2017 and December 2017 at Montpellier University Hospital on women followed-up in the department of genetics and their general practitionners (GP). Patients and their GP will be called by the investigators and questionnaire will be given to them. Questionnaire includes questions for patients and their GP. The primary endpoint was to determine the rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation. Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions. Secondary endpoint was to determine women' opinion on their GP : whether or not well managed for their BRCA 1 / 2 mutation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged over 18
  • Women
  • Living in France
  • Having a medical insurance

Exclusion criteria

  • Men
  • Dementia
  • Non frenchspeaker
  • Mental retardation
  • Being the subject of a guardianship or tutelage measure

Treatment and study plan

Questionnaire given to the two groups

Behavioral

Questionnaire given to the two groups :

Patients with BRCA ½ mutation GP

Primary outcomes

  1. The rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation.

    Time frame: 1 day

    Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions

Secondary outcomes

  1. Women' opinion on their GP

    Time frame: 1 day

    Women' opinion on their GP : whether or not well managed for their BRCA 1 / 2 mutation.

    The rate of GP wanting a formation in oncogenetic

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Role of General Practionners in Management of Women With BRCA1/2 Mutation

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Jul 7, 2017
Registry last updated
May 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.